Cancers Statistics

Overview

Cancers in Numbers

Cancers (ISSN: 2072-6694)

Founded: 2009 (Volumes: 13)

11,864 articles published so far

2626 articles have been cited 10 times or more

Impact Factor

Current Impact Factor: 6.639

5-year Impact Factor: 6.999

JCR category rank: Q1: Oncology


Impact Factor

Citable Items & Citations

Cancers Access Trend

Top 10 Cited Papers

Citations Article
Drug Resistance in Cancer: An Overview
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Cell Death Pathways in Photodynamic Therapy of Cancer
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
Cytokines in Cancer Immunotherapy
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
Assessment of the Evolution of Cancer Treatment Therapies
Citations Article
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis
 
Platinum Resistance in Ovarian Cancer: Role of DNA Repair
 
Reactive Oxygen Species in the Tumor Microenvironment: An Overview
 
Tumor-Associated Neutrophils in Cancer: Going Pro
 
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
 
Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms

Cancers Statistics from Scopus

CiteScore: 4.4
view Scopus page
SJR data, view statistics from SCImago

Cancers Statistics

Rejection Rates by Year

Publication Times



Back to TopTop